The results of 200 antenatal diagnoses in pregnancies at risk for homozygous r-thalassaemia, carried out on fetal blood samples obtained by placental aspiration in the second trimester, are described. Globin chain synthesis in the fetuses was measured by means of 3H-leucine incorporation and separation of the chains on carboxy-methyl-cellulose columns. Fetal red cell enrichment was performed by NH4Cl-N`H4HCO3 differential lysis of maternal cells or anti-i differential agglutination. Sufficient fetal blood for analysis was obtained in 97.5 % of the cases. The overall fetal loss rate was 6.5 %, but it declined from 10% in the first consecutive 100 cases to 3 % in the last 100 cases. Fetal loss was the result of early or late intrauterine death or spontaneous abortion. Forty-two homozygous fetuses had no 3-chain synthesis and one had a very low 3/ry ratio (0.005). Of the pregnancies, 37 were terminated at parental request and four aborted spontaneously. Absence of 5-chain radioactivity was confirmed in 12 abortuses with suitable cord blood samples for analysis. Two pregnancies with homozygous fetuses were not terminated, as one member of each couple was a devout Catholic. As expected, both infants developed Cooley's anaemia. Follow-up of the 146 infants, diagnosed in utero as non-homozygotes, showed cerebral palsy in one and a small cutaneous needle injury in three. None of these developed homozygous P-thalassaemia. Even P-thalassaemia trait with a F3/y ratio of 0.046 i 0-012 can be distinguished from normal, showing a r3/y ratio of 0-086 ± 0.019 with a high degree of certainty.
SUMMARY
The results of 200 antenatal diagnoses in pregnancies at risk for homozygous r-thalassaemia, carried out on fetal blood samples obtained by placental aspiration in the second trimester, are described. Globin chain synthesis in the fetuses was measured by means of 3H-leucine incorporation and separation of the chains on carboxy-methyl-cellulose columns. Fetal red cell enrichment was performed by NH4Cl-N`H4HCO3 differential lysis of maternal cells or anti-i differential agglutination. Sufficient fetal blood for analysis was obtained in 97.5 % of the cases. The overall fetal loss rate was 6.5 %, but it declined from 10% in the first consecutive 100 cases to 3 % in the last 100 cases. Fetal loss was the result of early or late intrauterine death or spontaneous abortion. Forty-two homozygous fetuses had no 3-chain synthesis and one had a very low 3/ry ratio (0.005). Of the pregnancies, 37 were terminated at parental request and four aborted spontaneously. Absence of 5-chain radioactivity was confirmed in 12 abortuses with suitable cord blood samples for analysis. Two pregnancies with homozygous fetuses were not terminated, as one member of each couple was a devout Catholic. As expected, both infants developed Cooley's anaemia. Follow-up of the 146 infants, diagnosed in utero as non-homozygotes, showed cerebral palsy in one and a small cutaneous needle injury in three. None of these developed homozygous P-thalassaemia. Even P-thalassaemia trait with a F3/y ratio of 0.046 i 0-012 can be distinguished from normal, showing a r3/y ratio of 0-086 ± 0.019 with a high degree of certainty.
Through advances in fetal blood samplingl-5 and development of biochemical methods for analysis of globin chains or haemoglobin synthesis of fetal reticulocytes,69 in the last few years prenatal diagnosis of homozygous P-thalassaemia and other inherited haemoglobin disorders has been shown to be feasible and accurate.10-9
In many countries where thalassaemia is prevalent and there is no social or ethical attitude against termination of pregnancy, such as in Greece, Cyprus, and Italy, a great demand for antenatal diagnosis has arisen. Up to March 1980 at least 1100 pregnancies at risk, including our series, have been monitored in several centres around the world (Alter, 1980, personal communication Forty-two fetuses with a r/y ratio of 0 and one with 0 *005 were presumed to be r-thalassaemia homozygotes (fig 3) .
Since globin chain synthesis analysis at birth was found to be inappropriate for the precise identification of 3-thalassaemia heterozygotes,29 3 we divided the non-homozygous fetuses into two groups. One included normal and heterozygous fetuses defined by complete haematological assessment, including Hb A. and F determination after the stage of haematological maturity (4 to 12 months after birth), and the other (non-homozygotes) had only globin chain synthesis analysis at birth. Twentyfour fetuses, diagnosed as normal at follow-up, had r/y globin chain synthesis ratios from 0 -049 to 0-120 with a mean of 0-086±0-019. Fifty-four fetuses, identified as r-thalassaemia heterozygotes at follow-up, had mean P/,y ratios of 0-046±0-012
Haematological and obstetric aspects of antenatal diagnosis of P-thalassaemia The second group (non-homozygotes) showed P/y ratios ranging from 0-028 to 0 142. They will be genotyped at follow-up examination. It is worth pointing out that the lowest value found in heterozygous fetuses was 0-028.
HAEMATOLOGICAL AND CLINICAL FOLLOW-UP
Of the 43 pregnancies diagnosed as having a (-thalassaemia homozygous fetus, 37 were terminated on parental request and four aborted spontaneously. After abortion, fetal blood was suitable for analysis in only 12 cases and the absence of 3-chains was confirmed. Two couples, with homozygous Pthalassaemia fetuses, decided to continue the pregnancy, as one member of each was a devout Catholic. Both these infants developed Cooley's anaemia with haematological findings consistent with homozygous (°-thalassaemia.
By biosynthetic measurement and/or cellulose tDiagnosed correctly in utero.
acetate pH 8 4 and agar gel pH 6-2 electrophoresis on cord blood or venous blood at 1 to 2 days, thalassaemia major was excluded in all the infants diagnosed in utero as non-homozygotes (table 6) . Seventy-eight infants, including all the offspring of pregnancies at risk for P31-thalassaemia, were followed up to haematological maturity (4 to 6 months). Of these, 30 * 7 % were normal and 69 * 3% were f-thalassaemia heterozygotes. No misdiagnosis was made (table 6) .
Discussion
This study, concerning a group of 200 pregnancies at risk for ,-thalassaemia, monitored by fetal blood sampling with placentocentesis and globin chain synthesis analysis of fetal blood, shows that antenatal diagnosis of homozygous ,B-thalassaemia is feasible and accurate, with acceptably low failure and fetal loss rates, confirming and expanding previous studies.12 14 16-18 Fetal blood sampling by needling in the second trimester has a high degree of success with a failure rate of only 2-5 %. Moreover, there was a decline in the failure rate from 3 % in the first series of 100 cases to 2% in the second 100 cases examined, through the obstetrician gaining experience and the introduction of 0rskov lysis, which allowed successful analysis even with relatively low fetal red blood cell percentages (less than 5 %). As we have already reported,16 17 The fetal loss rate was 6-5%, slightly higher in anterior than in posterior placentas (fig 1) . Interestingly, as was seen in the failure rate, the fetal loss rate had a continuous decline from 10 % seen in the first 100 consecutive cases to 3% in the last 100 examined. This too may be partially attributed to the increased experience in fetal blood sampling gained by the obstetrician and partially to the introduction of 0rksov lysis for fetal red cell concentration. In fact, with this technique the number of placental aspirations required have been minimised, because the procedure was stopped as soon as a minimum amount of fetal blood was obtained.
The fetal loss rate of 6 50% seen in our series is similar to the overall rate of 6-7 % observed in approximately 1O00 cases, including ours, studied in several centres around the world up to March 1980 (Alter, 1980, personal communication) and lower than the 9 * 5% noted by Matsakis et a132 in a group of 200 cases. In both these series sampling was carried out by needling or fetoscopy.
In our pregnancies fetal losses resulted from early or late intrauterine death and spontaneous abortion. Consistent fetomaternal transfusion was very rare, being observed in 0 5 % of the subjects.
Apart from fetal loss, no major adverse effect of the placentocentesis was seen in the mothers or the babies. A case of hemiplegic cerebral palsy was detected at follow-up, giving an incidence of 0 5%, slightly higher than the 0 *25 % figure already noted in a large series of newborns.33 It cannot be excluded that this complication resulted from the placental sampling. However, it should be noted that in this pregnancy needling was performed easily and was successful at the first attempt with withdrawal of only two small placental samples.
The risk of physical injury to the fetus is real, as is shown by the placentocentesis needle injury found in three babies. However, from our experience the risk appears slight and the injuries minor. Finally, from the limited data collected to date, it seems that there was no major adverse effect of placentocentesis on child growth and development (unpublished observations).
Both anti-i differential agglutination and 0rskov lysis may result in satisfactory fetal red cell enrichment, as has already been seen.14 15 Since the availability of high titre anti-i is limited and anti-i differential agglutination is inefficient in samples containing less than 5 % fetal red blood cells, 0rskov lysis could be considered the best method for fetal red cell enrichment. However, at times a satisfactory fetal red blood cell concentration could not be obtained with this method. It is worth noting that the samples in which 0rskov lysis failed could be successfully enriched with anti-i.
The biochemical analysis of fetal blood with globin chain synthesis analysis seems to be extremely accurate. In the pregnancy at risk for sickle cell/P0-thalassaemia, both fs-and 3A-globin chain synthesis 
